FDA Should Validate Effectiveness Of Risk Management Tools, PhRMA Says
Executive Summary
FDA risk management programs should be evaluated by the agency to determine the value of their implementation, the Pharmaceutical Research & Manufacturers of America maintained during a public workshop on risk management April 10